Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 4. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 5. Rapid correction of low vitamin D status in nursing home residents
Your Article Summary
See Latest ArticlesLanreotide Reduces the Volume of Polycystic Liver: A Randomized, Double-Blind, Placebo-Controlled Trial
Gastroenterology, 10/28/09
Keimpema LV et al. – In patients with polycystic liver, 6 months of treatment with lanreotide reduces liver volume.
Related Articles
Recognizing and treating cutaneous signs of liver disease
Cleveland Clinic Journal of Medicine, 10/05/09
Relevance Score: 71%
Drinking Coffee Slows Progression Of Liver Disease In Chronic Hepatitis C Sufferers
ScienceDaily, 10/26/09
Relevance Score: 70%
Drinking coffee slows progression of liver disease in chronic hepatitis C sufferers
EurekAlert, 10/21/09
Relevance Score: 70%
Statin therapy initiated in a man with hepatitis C and elevated cholesterol
The Clinical Advisor, 10/07/09
Relevance Score: 70%
Effect of Mild and Moderate Liver Disease on the Pharmacokinetics of Isavuconazole after Intravenous and Oral Administration of a Single Dose of the Prodrug BAL8557
Antimicrobial Agents and Chemotherapy, 11/05/09
Relevance Score: 69%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Interferon-gamma (INF-gamma) release test can detect cutaneous adverse effects to statins
International Journal of Dermatology, 12/03/09
Amlodipine/Valsartan/Hydrochlorothiazide: Fixed-Dose Combination in Hypertension
American Journal of Cardiovascular Drugs, 12/03/09
Beta-Blocker Therapy and Mortality of Patients with Chagas' Cardiomyopathy—a subanalysis of the REMADHE prospective trial
Circulation: Heart Failure, 12/03/09
Sponsor
Article Search
Sponsor
Sponsor